• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不完全抑制Dll4/Notch信号通路可促进功能性血管生成,支持皮肤乳头瘤生长。

Incomplete Dll4/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas.

作者信息

Djokovic Dusan, Trindade Alexandre, Gigante Joana, Pinho Mario, Harris Adrian L, Duarte Antonio

机构信息

Centro Interdisciplinar de Investigação em Sanidade Animal (CIISA), Universidade de Lisboa (ULisboa), Lisbon, Portugal.

Cancer Research UK Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

出版信息

BMC Cancer. 2015 Aug 28;15:608. doi: 10.1186/s12885-015-1605-2.

DOI:10.1186/s12885-015-1605-2
PMID:26314892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4552132/
Abstract

BACKGROUND

In invasive malignancies, Dll4/Notch signaling inhibition enhances non-functional vessel proliferation and limits tumor growth by reducing its blood perfusion.

METHODS

To assess the effects of targeted Dll4 allelic deletion in the incipient stages of tumor pathogenesis, we chemically induced skin papillomas in wild-type and Dll4 (+/-) littermates, and compared tumor growth, their histological features, vascularization and the expression of angiogenesis-related molecules.

RESULTS

We observed that Dll4 down-regulation promotes productive angiogenesis, although with less mature vessels, in chemically-induced pre-cancerous skin papillomas stimulating their growth. The increase in endothelial activation was associated with an increase in the VEGFR2 to VEGFR1 ratio, which neutralized the tumor-suppressive effect of VEGFR-targeting sorafenib. Thus, in early papillomas, lower levels of Dll4 increase vascularization through raised VEGFR2 levels, enhancing sensitivity to endogenous levels of VEGF, promoting functional angiogenesis and tumor growth.

CONCLUSION

Tumor promoting effect of low-dosage inhibition needs to be considered when implementing Dll4 targeting therapies.

摘要

背景

在侵袭性恶性肿瘤中,Dll4/Notch信号通路抑制可增强无功能血管增殖,并通过减少肿瘤血供来限制肿瘤生长。

方法

为评估在肿瘤发病初期靶向Dll4等位基因缺失的影响,我们在野生型和Dll4(+/-)同窝小鼠中化学诱导皮肤乳头状瘤,并比较肿瘤生长、组织学特征、血管生成以及血管生成相关分子的表达。

结果

我们观察到,在化学诱导的癌前皮肤乳头状瘤中,Dll4下调促进了有功能的血管生成,尽管血管不太成熟,从而刺激了肿瘤生长。内皮细胞激活增加与VEGFR2与VEGFR1比值增加有关,这抵消了靶向VEGFR的索拉非尼的肿瘤抑制作用。因此,在早期乳头状瘤中,较低水平的Dll4通过提高VEGFR2水平增加血管生成,增强对内源性VEGF水平的敏感性,促进有功能的血管生成和肿瘤生长。

结论

在实施Dll4靶向治疗时,需要考虑低剂量抑制的促肿瘤作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/275cb3adf03a/12885_2015_1605_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/0e4c9937c30a/12885_2015_1605_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/2be6414cc184/12885_2015_1605_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/bb5132f314c3/12885_2015_1605_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/275cb3adf03a/12885_2015_1605_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/0e4c9937c30a/12885_2015_1605_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/2be6414cc184/12885_2015_1605_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/bb5132f314c3/12885_2015_1605_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ed/4552132/275cb3adf03a/12885_2015_1605_Fig4_HTML.jpg

相似文献

1
Incomplete Dll4/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas.不完全抑制Dll4/Notch信号通路可促进功能性血管生成,支持皮肤乳头瘤生长。
BMC Cancer. 2015 Aug 28;15:608. doi: 10.1186/s12885-015-1605-2.
2
Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.DLL4/VEGF 双特异性治疗性抗体与伊立替康联合应用在胃癌中的协同抗肿瘤活性。
BMB Rep. 2020 Nov;53(10):533-538. doi: 10.5483/BMBRep.2020.53.10.103.
3
Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.Dll4/Notch 和 Ephrin-B2/EphB4 联合靶向治疗可有效破坏肿瘤血管生成。
BMC Cancer. 2010 Nov 23;10:641. doi: 10.1186/1471-2407-10-641.
4
Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis.低剂量抑制 Dll4 信号转导通过诱导功能性新血管生成促进伤口愈合。
PLoS One. 2012;7(1):e29863. doi: 10.1371/journal.pone.0029863. Epub 2012 Jan 18.
5
Gamma-Secretase Inhibitor, DAPT, Prevents the Development of Retinopathy of Prematurity in a Rat Model by Regulating the Delta-Like Ligand 4/Notch Homolog-1 (DLL4/Notch-1) Pathway.γ-分泌酶抑制剂 DAPT 通过调节 Delta 样配体 4/Notch 同源物-1(DLL4/Notch-1)通路预防早产视网膜病变在大鼠模型中的发生。
Med Sci Monit. 2019 Jan 17;25:492-499. doi: 10.12659/MSM.913828.
6
Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.骨髓来源的表达 Delta-like 4(Dll4)的内皮祖细胞调节肿瘤血管生成。
PLoS One. 2011 Apr 4;6(4):e18323. doi: 10.1371/journal.pone.0018323.
7
Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.在肺癌患者缺氧条件下,VEGF 和 Dll4/Notch 通路分子的异常表达及相关性。
Histol Histopathol. 2013 Feb;28(2):277-84. doi: 10.14670/HH-28.277.
8
Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo.内皮细胞中Dll4的过表达会降低血管反应,并在体内抑制肿瘤生长和转移。
BMC Cancer. 2017 Mar 14;17(1):189. doi: 10.1186/s12885-017-3171-2.
9
Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes.内皮细胞 HIF-2α 调控小鼠病理性血管生成和再血管化过程。
J Clin Invest. 2012 Apr;122(4):1427-43. doi: 10.1172/JCI57322. Epub 2012 Mar 19.
10
DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.DLL4-Notch 信号通路介导肿瘤在体内对抗 VEGF 治疗的耐药性。
Cancer Res. 2011 Sep 15;71(18):6073-83. doi: 10.1158/0008-5472.CAN-11-1704. Epub 2011 Jul 29.

引用本文的文献

1
Tensile Stress-Activated and Exosome-Transferred YAP/TAZ-Notch Circuit Specifies Type H Endothelial Cell for Segmental Bone Regeneration.张拉力激活和外泌体传递的 YAP/TAZ-Notch 通路特异性指定 H 型血管内皮细胞用于节段性骨再生。
Adv Sci (Weinh). 2024 Mar;11(12):e2309133. doi: 10.1002/advs.202309133. Epub 2024 Jan 15.
2
2 Window NIR Imaging of Radiation Injury Mitigation Provided by Reduced Notch-Dll4 Expression on Vasculature.2 窗口近红外成像显示血管中 Notch-Dll4 表达减少可减轻辐射损伤。
Mol Imaging Biol. 2024 Feb;26(1):124-137. doi: 10.1007/s11307-023-01840-7. Epub 2023 Aug 2.
3
High expression of Dll4 and CD44V6 is associated with clinicopathological characteristics and poor prognosis in osteosarcoma patients.

本文引用的文献

1
Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.Delta样配体4(Dll4)可预测透明细胞肾细胞癌的预后,且抗Dll4可在体内抑制肿瘤生长。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2143-52. eCollection 2014.
2
Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma.DLL4 表达升高与 VEGF 相关,并预示鼻咽癌预后不良。
Med Oncol. 2013 Mar;30(1):390. doi: 10.1007/s12032-012-0390-x. Epub 2012 Dec 30.
3
Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis.
Dll4和CD44V6的高表达与骨肉瘤患者的临床病理特征及不良预后相关。
Transl Cancer Res. 2021 Feb;10(2):1065-1072. doi: 10.21037/tcr-21-31.
4
Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas.针对移动和隐藏目标的射击——头颈部鳞状细胞癌中的肿瘤细胞可塑性与Notch信号通路
Cancers (Basel). 2021 Dec 10;13(24):6219. doi: 10.3390/cancers13246219.
5
Genetically modified endothelial progenitor cells with hNotch1.ICN overexpression display facilitated angiogenesis.过表达hNotch1.ICN的基因修饰内皮祖细胞表现出促进血管生成的作用。
Ann Transl Med. 2020 Oct;8(20):1316. doi: 10.21037/atm-20-6362.
6
The Role of DLLs in Cancer: A Novel Therapeutic Target.DLLs在癌症中的作用:一种新型治疗靶点。
Onco Targets Ther. 2020 May 7;13:3881-3901. doi: 10.2147/OTT.S244860. eCollection 2020.
7
Tumor suppressive effects of the pleiotropically acting miR-195 in colorectal cancer cells.多效性作用的miR-195在结肠癌细胞中的肿瘤抑制作用。
EXCLI J. 2019 Apr 9;18:243-252. doi: 10.17179/excli2019-1166. eCollection 2019.
8
Metastasis is impaired by endothelial-specific Dll4 loss-of-function through inhibition of epithelial-to-mesenchymal transition and reduction of cancer stem cells and circulating tumor cells.内皮细胞特异性 Dll4 功能丧失可通过抑制上皮间质转化、减少癌症干细胞和循环肿瘤细胞来抑制转移。
Clin Exp Metastasis. 2019 Aug;36(4):365-380. doi: 10.1007/s10585-019-09973-2. Epub 2019 May 22.
9
Revision of the concept of anti-angiogenesis and its applications in tumor treatment.抗血管生成概念的修订及其在肿瘤治疗中的应用
Chronic Dis Transl Med. 2017 Mar 8;3(1):33-40. doi: 10.1016/j.cdtm.2017.01.002. eCollection 2017 Mar 25.
低剂量抑制 Dll4 信号转导通过诱导功能性新血管生成促进伤口愈合。
PLoS One. 2012;7(1):e29863. doi: 10.1371/journal.pone.0029863. Epub 2012 Jan 18.
4
Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development.Costello 综合征的皮肤表型:Ras 失调对发育的影响。
Br J Dermatol. 2012 Mar;166(3):601-7. doi: 10.1111/j.1365-2133.2011.10744.x.
5
High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.Delta-like 配体 4 高表达预示着胰腺癌根治性切除术后预后不良。
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S464-74. doi: 10.1245/s10434-011-1968-9. Epub 2011 Aug 6.
6
Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion.γ-分泌酶抑制剂治疗促进 VEGF-A 驱动的血管生长和血管渗漏,但破坏新血管灌注。
PLoS One. 2011 Apr 14;6(4):e18709. doi: 10.1371/journal.pone.0018709.
7
Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.Dll4/Notch 和 Ephrin-B2/EphB4 联合靶向治疗可有效破坏肿瘤血管生成。
BMC Cancer. 2010 Nov 23;10:641. doi: 10.1186/1471-2407-10-641.
8
Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity.在肿瘤中靶向 DLL4 显示出临床前活性,但具有潜在的显著毒性。
Future Oncol. 2010 Jul;6(7):1099-103. doi: 10.2217/fon.10.62.
9
Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma.针对血管顶端细胞抗原 delta 样配体 4 的 DNA 疫苗在乳腺癌中的治疗效果。
Oncogene. 2010 Jul 29;29(30):4276-86. doi: 10.1038/onc.2010.176. Epub 2010 May 24.
10
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.Ephrin-B2 调节血管内皮生长因子受体 2 在发育和肿瘤血管生成中的功能。
Nature. 2010 May 27;465(7297):487-91. doi: 10.1038/nature08995. Epub 2010 May 5.